Paper1850498
Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid).
Warrell RP and 9 others. N Engl J Med, 1991. Cited by 1,289 papers, by iCite.
Cite this record
ConductScience Library. Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid). Papers, record 1850498. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1850498
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Leukemia, Promyelocytic, Acute | Major topic |
| Tretinoin | Major topic |
| Administration, Oral | |
| Adolescent | |
| Adult | |
| Aged | |
| Carrier Proteins | |
| Child | |
| Chromosome Aberrations | |
| Female | |
| Flow Cytometry | |
| Humans | |
| Immunoblotting | |
| Leukocyte Count | |
| Male | |
| Middle Aged | |
| Neoplasm Proteins | |
| Receptors, Retinoic Acid | |
| Remission Induction |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| CA-09207-14 | NCI NIH HHS | United States | PubMed | PubMed | |
| FD-R-000674 | FDA HHS | United States | PubMed | PubMed | |
| R01FD000674 | NIH | NIH RePORTER | |||
| T32CA009207 | NIH | NIH RePORTER |
Cited by272
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,289 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42433709 | Fenretinide in cancer therapy and chemoprevention: past, present and future. | Cancer Drug Resist | 2026 | https://conductscience.org/library/papers/42433709 | PubMed |
| 42329216 | An optimized method to differentiate HL60 cells into neutrophil-like cells. | J Leukoc Biol | 2026 | https://conductscience.org/library/papers/42329216 | PubMed |
| 42131682 | Isotretinoin Use During Consolidation in Acute Promyelocytic Leukemia Following Standard All-Trans Retinoic Acid (ATRA)-Based Induction: A Case Report. | Cureus | 2026 | https://conductscience.org/library/papers/42131682 | PubMed |
| 42062396 | Differential regulation of retinoic acid metabolism in Fanconi anemia. | Sci Rep | 2026 | https://conductscience.org/library/papers/42062396 | PubMed |
| 41542487 | AN OPTIMIZED METHOD TO DIFFERENTIATE HL60 CELLS INTO NEUTROPHIL-LIKE CELLS. | bioRxiv | 2026 | https://conductscience.org/library/papers/41542487 | PubMed |
| 41279885 | Virtual Clinical Trials of BMP4 Differentiation Therapy: Digital Twins to Aid Successful Glioblastoma Trial Design. | bioRxiv | 2025 | https://conductscience.org/library/papers/41279885 | PubMed |
| 41239429 | Early mortality in patients with acute promyelocytic leukemia: a systematic review and meta-analysis. | Crit Care | 2025 | https://conductscience.org/library/papers/41239429 | PubMed |
| 40505660 | Derepressing nuclear pyruvate dehydrogenase induces therapeutic cancer cell reprogramming. | Cell Metab | 2025 | https://conductscience.org/library/papers/40505660 | PubMed |
| 40141362 | Prolonged Low-Dose Administration of FDA-Approved Drugs for Non-Cancer Conditions: A Review of Potential Targets in Cancer Cells. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40141362 | PubMed |
| 39687864 | Chaperone-mediated autophagy as a modulator of aging and longevity. | Front Aging | 2024 | https://conductscience.org/library/papers/39687864 | PubMed |
| 39682277 | Acute Promyelocytic Leukemia in the Real World: Understanding Outcome Differences and How We Can Improve Them. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/39682277 | PubMed |
| 38952949 | Acute myeloid leukemia with a novel AKAP9::PDGFRA fusion transformed from essential thrombocythemia: A case report and mini review. | Leuk Res Rep | 2024 | https://conductscience.org/library/papers/38952949 | PubMed |
| 38611029 | History of Developing Acute Promyelocytic Leukemia Treatment and Role of Promyelocytic Leukemia Bodies. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/38611029 | PubMed |
| 38431691 | Inhibition of mitochondrial folate metabolism drives differentiation through mTORC1 mediated purine sensing. | Nat Commun | 2024 | https://conductscience.org/library/papers/38431691 | PubMed |
| 38275101 | The phenotypic reversion of cancer: Experimental evidences on cancer reversibility through epigenetic mechanisms (Review). | Oncol Rep | 2024 | https://conductscience.org/library/papers/38275101 | PubMed |
| 38272890 | Generation of a new therapeutic D-peptide that induces the differentiation of acute myeloid leukemia cells through A TLR-2 signaling pathway. | Cell Death Discov | 2024 | https://conductscience.org/library/papers/38272890 | PubMed |
| 37963209 | Lineage Plasticity: The New Cancer Hallmark on the Block. | Cancer Res | 2024 | https://conductscience.org/library/papers/37963209 | PubMed |
| 37745860 | Characterization and therapeutic perspectives of differentiation-inducing therapy in malignant tumors. | Front Genet | 2023 | https://conductscience.org/library/papers/37745860 | PubMed |
| 37689790 | A novel retinoic acid receptor-γ agonist antagonizes immune checkpoint resistance in lung cancers by altering the tumor immune microenvironment. | Sci Rep | 2023 | https://conductscience.org/library/papers/37689790 | PubMed |
| 37597697 | Discovery of 5-sulfonyltetrazoles as neuroblastoma differentiation agents. | Bioorg Med Chem Lett | 2023 | https://conductscience.org/library/papers/37597697 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| RARA | 5914 | PubTator's text mining | https://conductscience.org/library/genes/5914 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/1850498
GET https://conductscience.org/api/papers/v1/1850498/cited_by?page=2